Evidence map›Paper›PMID 32080251›Full record

ArticleScientific reports2020

Chromosome 19 microRNA cluster enhances cell reprogramming by inhibiting epithelial-to-mesenchymal transition.

Ezinne F Mong, Ying Yang, Kemal M Akat, John Canfield, Jeffrey VanWye, John Lockhart, John C M Tsibris, Frederick Schatz, Charles J Lockwood, Thomas Tuschl and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. The Role of Cluster C19MC in Pre-Eclampsia Development.International journal of molecular sciences · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ezinne F MongDepartment of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Ying YangDepartment of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Kemal M AkatHoward Hughes Medical Institute and Laboratory for RNA Molecular Biology, The Rockefeller University, New York, New York, USA.
John CanfieldDepartment of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Jeffrey VanWyeDepartment of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
John LockhartDepartment of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.ORCID http://orcid.org/0000-0002-2727-6969
John C M TsibrisDepartment of Obstetrics and Gynecology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Frederick SchatzDepartment of Obstetrics and Gynecology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Charles J LockwoodDepartment of Obstetrics and Gynecology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Thomas TuschlHoward Hughes Medical Institute and Laboratory for RNA Molecular Biology, The Rockefeller University, New York, New York, USA.
Umit A KayisliDepartment of Obstetrics and Gynecology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA.
Hana Totary-JainDepartment of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA. totaryjainh@usf.edu.ORCID http://orcid.org/0000-0003-2203-0377
University of South Florida · USHoward Hughes Medical Institute · US

Funding

MicroRNA-Based, Cell-Selective Therapy for Coronary Artery DiseaseR01HL128411 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI TOTARY-JAIN, HANA · 2015 to 2025
$4.3M
Molecular mechanisms enhancing lymphatic valve formationR01HL145397 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI YANG, YING · 2019 to 2023
$1.9M
MicroRNA Detargeting Novel Therapy for Coronary Artery DiseaseR00HL109133 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI TOTARY-JAIN, HANA · 2014 to 2016
$738k
MicroRNA Detargeting Novel Therapy for Coronary Artery DiseaseK99HL109133 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TOTARY-JAIN, HANA · 2011 to 2012
$268k
NHLBI NIH HHS K99 HL109133NHLBI NIH HHS R00 HL109133NHLBI NIH HHS R01 HL128411NHLBI NIH HHS R01 HL145397
6 · The paper itself

Abstract

During implantation, cytotrophoblasts undergo epithelial-to-mesenchymal transition (EMT) as they differentiate into invasive extravillous trophoblasts (EVTs). The primate-specific microRNA cluster on chromosome 19 (C19MC) is exclusively expressed in the placenta, embryonic stem cells and certain cancers however, its role in EMT gene regulation is unknown. In situ hybridization for miR-517a/c, a C19MC cistron microRNA, in first trimester human placentas displayed strong expression in villous trophoblasts and a gradual decrease from proximal to distal cell columns as cytotrophoblasts differentiate into invasive EVTs. To investigate the role of C19MC in the regulation of EMT genes, we employed the CRISPR/dCas9 Synergistic Activation Mediator (SAM) system, which induced robust transcriptional activation of the entire C19MC cistron and resulted in suppression of EMT associated genes. Exposure of human iPSCs to hypoxia or differentiation of iPSCs into either cytotrophoblast-stem-like cells or EVT-like cells under hypoxia reduced C19MC expression and increased EMT genes. Furthermore, transcriptional activation of the C19MC cistron induced the expression of OCT4 and FGF4 and accelerated cellular reprogramming. This study establishes the CRISPR/dCas9 SAM as a powerful tool that enables activation of the entire C19MC cistron and uncovers its novel role in suppressing EMT genes critical for maintaining the epithelial cytotrophoblasts stem cell phenotype.

Indexed as

BiomarkersCell DifferentiationCell HypoxiaCellular ReprogrammingChromosomes, Human, Pair 19Epithelial-Mesenchymal TransitionFemaleGene Expression RegulationHEK293 CellsHumansInduced Pluripotent Stem CellsMicroRNAsMultigene FamilyPlacentaPregnancyTranscriptional ActivationBiomarkersMicroRNAs

Identifiers

PMID32080251
PMCPMC7033247
OpenAlexW3008455426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.